While outsourcing respondents currently hold mixed opinions on conducting hybrid trials (some traditional and some decentralized components), over two-thirds either currently use or plan to use them in the next two years. Respondents also anticipate that hybrid trials will make up a greater proportion of their studies two years from now. This is starkly illustrated in the bar graph below, where 14% of respondents currently—and 31% two years from now—use hybrid strategies for at least 40% of their trials.

Originally published in Life Science Leader.

View File